• Programme
  • In vitro
    demonstration
  • Pre-clinical
    trials
  • Safety
    trials
  • Follow-on
    trials
  • Market
  • STAGE*
  • 1
  • 2
  • 3
  • 4
  • 5

  • Malaria
  •  
  •  
  •  
  •  
  •  

  • Sepsis
  •  
  •  
  •  
  •  
  •  

  • Leukaemia
  •  
  •  
  •  
  •  
  •  

*Programme Stage Key

1 - In vitro demonstration /  2 - Pre-clinical trials /  3 - Safety trials /  4 - Follow-on trials / 5 - Market

Latest News

MediSieve expands its research into treating COVID-19

MediSieve expands its research into treating COVID-19
April 29, 2020

Recent studies show that patients with the most serious forms of the coronavirus had high levels of something called IL-6, a common inflammatory cytokine, which MediSieve has previously encountered while researching sepsis and cytokine storms.
COVID-19 Response

COVID-19 Response
April 03, 2020

Recent clinical data has shown that >50 per cent of hospitalised COVID-19 patients develop cytokine storm syndromes, and that these are a major driver of mortality.